Yahong Peng - Concepedia

Author

Yahong Peng

Pfizer (United States)ORCID

Also Known As

Daniel Scott, Samantha Munson, William C Gruber, Y. Peng, Yahong Peng

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Janssen (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)Pfizer (Japan)PMG Research

About

Yahong Peng is an author at Pfizer (United States) specializing in medicine, vaccination, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	264
2	Health Sciences	2	2	63
3	Public Health	1	1	68
4	Epidemiology	1	1	15
5	Geriatrics	1	1	24

Yahong Peng

Publications

981

Citations

H-Index

Page 1

	Year	Citations
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years Brandon Essink, Charu Sabharwal, Kevin Cannon, Clinical Infectious Diseases	2021	154
Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease Florence Pasquier, Carl Sadowsky, Ann R Holstein, Journal of Alzheimer s Disease	2016	101
Growth hormone secretagogue MK-677 Jeffrey Sevigny, Jillian Ryan, C H van Dyck, Neurology	2008	84
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination Kevin Cannon, Charles Elder, Mariano Young, Vaccine VaccinationVaccinologyVaccine SafetyPreventive MedicineVaccine Surveillance	2021	77
A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults Eric Sheldon, Nicholas Kitchin, Yahong Peng, Vaccine VaccinationVaccine SafetyVaccine DevelopmentRandomized StudyAluminum Hydroxide	2016	68
Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: Results From a Double‐Blind, Single‐Attack Study and Two Open‐Label, Multiple‐Attack Studies W. Hester Visser, Paul Winner, Kim M. Strohmaier, Headache The Journal of Head and Face Pain	2004	64
Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease Michael Hüll, Carl Sadowsky, Heii Arai, Current Alzheimer Research	2017	60
Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States Shelly Senders, Nicola P. Klein, Erik Lamberth, The Pediatric Infectious Disease Journal	2021	60
A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years Nicholas Kitchin, Shon Remich, James T. Peterson, Clinical Infectious Diseases	2019	51
Pilot Randomized Controlled Study of a Histamine Receptor Inverse Agonist in the Symptomatic Treatment of AD Michael Egan, R. Yaari, Lian Liu, Current Alzheimer Research NeuropsychologyElderly PatientsPsychopharmacologyNeuropsychiatryPharmacotherapy	2012	39

Page 1